Number of qualified sufferers: CDEC mentioned the uncertainty in the number of people with reasonably extreme to significant hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical authorities consulted by CADTH indicated that some individuals who are categorized as having delicate or reasonable condition could have a serious bleeding phenotype, https://marcochjkk.pages10.com/not-known-factual-statements-about-hemgenix-71223744